SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for a highly visible role that is responsible for the development, coordination and execution of epidemiology/ pharmaco-epidemiology strategy across programs and throughout all phases of product lifecycle. The Associate Director of Epidemiology has subject matter expertise in general epidemiology and pharmacoepidemiology methods and will advise development and post-marketing programs regarding focus disease populations, epidemiologic query support, and execution of outcomes research studies across the portfolio.
Roles and Responsibilities
Perform critical appraisal and synthesis of relevant epidemiological literature, including to support exploration of new disease areas
Provide strategic epidemiologic input into development plans across product lifecycle
Provide subject matter expertise, guidance and direction to internal and external stakeholders
Lead epidemiologic literature searches as well as support analyses of epidemiologic data sets to aid business planning, ad hoc queries, and aggregate reports
Ensure oversight of observational studies to describe and quantify disease epidemiology and real-world usage, and effectiveness
Maintain up-to-date knowledge of industry best practices in epidemiology and recognized as internal expert and go-to person
Collaborate on Global Value Dossier, Value Proposition, and Pharmacoeconomic model development
Collaborate with Publication team to align and support global publication strategy and dissemination of research findings at conferences and peer review journals
Assist in the development and establishment of processes and procedures to maximize HEOR and epi operational excellence
Identify, select, establish and manage a global network of contractors, consultants, and CROs to execute planned epi deliverables
Develop and maintain a strong network of professional contacts
Experience, Education and Specialized Knowledge and Skills
Must thrive working in a fast-paced, innovative environment while remaining flexible, proactive, resourceful and efficient. Excellent interpersonal skills, ability to develop important relationships with key stakeholders, good conflict management and negotiation skills, ability to analyze complex issues to develop relevant and realistic plans, programs and recommendations. Demonstrated ability to translate strategy into action; excellent analytical skills and an ability to communicate complex issues in a simple way and to orchestrate plans to resolve issues and mitigate risks.
At least 5 years’ experience in pharmaceutical/biotechnology industry, CRO, or drug development company in HEOR, epidemiology, or similar function
PhD in epidemiology is strongly preferred, at least a Masters level degree required
Excellent analytical skills, including in-depth knowledge of epidemiology methodologies; experience in aspects of health economic analyses preferred
Broad experience with a range of US and international public and commercial epidemiologic databases
Experience in providing subject matter expert support to Commercial for long range planning and business development exercises preferred
Experience working with all levels of management and consulting with key business stakeholders. An ability to influence for greater outcomes
Strong team player that has a customer service approach and is solution oriented.
Attention to detail and the ability to work individually, within a multi-disciplinary team, as well as with external partners and vendors
Experience in managing multiple projects across a variety of therapeutic areas
Possesses strong written and verbal communication skills
Embrace our core values: Put People First, Do Big, Be Accountable, Grow through Learning and Change, and Work Fun
Excitement about the vision and mission of Sage
About Sage Therapeutics
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. Sage is thinking differently about drug development by using a focused, practical and deliberate approach. We responsibly pursue expedited pathways in our efforts to deliver new treatments for CNS disorders.